top of page
Hero image- Boy sleeps with his toy

Slenyto

®

Sleep more. Rest more.

Achieve more.

what is Slenyto?

Why Slenyto®?

​

Slenyto® is the first and only pharmacotherapy that is approved for the treatment of insomnia in children with Autism Spectrum Disorder (ASD), Neurogenetic Disorders (NGDs) and Attention-Deficit Hyperactivity Disorder (ADHD).

Slenyto® is a prolonged-release melatonin minitablet developed specifically for the treatment of insomnia in these children, addressing their specific needs. 

Slenyto symbol
Slenyto package
Benefits
Taking Slenyto​
​

  • Just 3mm diameter

  • Dose adjustable

  • Favourable safety 

Blue Background
Taking Slenyto icon-glass of water and pill
Provem Clinical Evidence icon- Checklist board with big "v" sign
Proven Clinical Evidence
​

  • Improves main sleep parameters

  • Improves daytime behavior

  • Improves parents well-being

Blue Background
Easy to Manage​
​

  • Doze optimization

  • Treatment evaluation

Blue Background
Easy to manage icon- Checklist board and pills
Insomnia & Autism
Pensive child sitting with a blue and yellow Q

Insomnia & ASD

​

50-80% of children with ASD suffer from insomnia, much more than typically developed children.  

Sleep deficit exacerbates cognitive and behavioural problems in ASD children and adolescent, and is also challenging for their families.

Quote
It takes her 2-3 hours to fall asleep and then she wakes up many times during the night. When she is trying to fall asleep, she jerks her body and bangs her head in the wall or bed. I haven't slept in the past 3 years.
Quote
/ A mother to a 3 years old girl diagnosed with ASD
bottom of page